Table 2. Summary of treatment-related adverse events.

	Grades 1 and 2		Grade 3		Grade 4
	N	%	N	%	N	%
Leukopenia	8	17.4	4	8.7	6	13.0
Neutropenia	6	13	7	15.2	8	17.4
Lymphopenia	19	41.3	12	26.1	1	2.2
Febrile neutropenia	—	—	—	—	6	13.0
Anaemia	34	74	4	8.7	—	—
Thrombocytopenia	4	8.7	—	—	3	6.5
Nausea	3	6.5	—	—	—	—
Vomiting	6	13	1	2.2	—	—
Diarrhoea	5	10.8	2	4.3	—	—
Mucositis	3	6.5	—	—	—	—
Constipation	2	4.4	—	—	—	—
Neurotoxicity	5	10.9	—	—	—	—
Skin toxicity	4	8.7	—	—	—	—
Allergy	1	2.2	—	—	—	—
Infection	7	15.2	3	6.5	—	—
Fever	10	21.8	—	—	—	—
Fatigue	22	47.8	2	4.3	—	—
Oedema	1	2.2	—	—	—	—
Transaminase elevation	6	13	—	—	—	—
Dyspnoea	18	39.1	1	2.2	—	—
Nephrotoxicity	3	6.5	—	—	—	—
Headache	2	4.4	—	—	—	—